Results of Extraordinary General Meeting of Shareholders to approve proposed GSK Transaction ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen Holdings”) RESULTS OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO APPROVE PROPOSED GSK TRANSACTION Shareholders are referred to the announcement released by Aspen Holdings on 30 June 2013 wherein it was confirmed that it would be proposed to shareholders of Aspen Holdings that Aspen Global Incorporated (“AGI”), a wholly owned subsidiary of Aspen Holdings, acquire from GlaxoSmithKline plc (“GSK”) the Arixtra and Fraxiparine/Fraxodi brands (“the Brands”) and business worldwide, except in China, Pakistan and India (“the Excluded Territories”) and Aspen Holdings acquire from GSK a specialised sterile production site which manufactures the Brands at Notre Dame de Bondeville, France (“the Site”), collectively (“the Proposed Transaction”). It was also confirmed that the aggregate purchase consideration payable by Aspen Holdings and AGI in respect of the Proposed Transaction was £600 million. As the Proposed Transaction was categorised as a Category 2 transaction in terms of the Listings Requirements of the JSE, with GSK being a material shareholder and a related party to Aspen Holdings, shareholders were requested to approve the Proposed Transaction by means of an ordinary resolution (i.e. with 50% of the votes cast in favour of the Proposed Transaction), excluding shares held by GSK and its associates, at a general meeting of shareholders called for this purpose on 8 November 2013. Aspen has pleasure in confirming that the ordinary resolution put to shareholders to approve the Proposed Transaction at this general meeting was carried with 100% of votes having been cast in favour of it. Durban 11 November 2013 Underwriters The Standard Bank of South Africa Limited Bank of America, N.A. Mandated Lead Arrangers and Bookrunners The Standard Bank of South Africa Limited Banc of America Securities Limited Sponsor: Investec Bank Limited Date: 11/11/2013 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.